Fenwick & West and Wilson Sonsini Goodrich & Rosati represented Metagenomi on the deal.Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation CRISPR-based…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
